Amyotrophic Lateral Sclerosis
Lancet 400:1363-1380, Feldman, E.L.,et al, 2022
Amyotrophic Lateral Sclerosis
NEJM 377:162-172, Brown, R.H.,et al, 2017
Degenerative Diseases of the Nervous System, Amyotrophic Lateral Sclerosis
Adams & Victors Principles of Neurology, Chp 39, pg 1109, Ropper, A.H.,et al, 2014
Practice Parameter Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Drug, Nutritional, and Respiratory Therapies (An Evidence-Based Review)
Neurol 73:1218-1226, Miller,R.G.,et al, 2009
Diagnosis and Management of Motor Neurone Disease
BMJ 336:658-662, McDermott,C.J. &Shaw,P.J., 2008
What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008
ALS Patients on TPPV
Neurol 61:135-137, Hayashi,H. &Oppenheimer,E.A., 2003
Amyotrophic Lateral Sclerosis
NEJM 344:1688-1700, Rowland,L.P. & Shneider,N.A., 2001
Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999
ALS Standard of Care Consensus
Neurol 48 (Suppl 4) :S33-S37997., Miller,R.G.,et al, 1997
Practice Advisory on the Trtm of ALS with Riluzole
Quality Standards Subcommittee of the AAN, Neurol 49:657-6591997., , 1997
Riluzole
Lancet 348:795-799, Wokke,J., 1996
Motor Neuron Disease
JNNP 57:886-896, Leigh,P.N.&Ray-Chaudhuri,K., 1994
Recent Developments in the Drug Treatment of Motor Neurone Disease
BMJ 309:140-141, , 1994
Competent Pts with Adv States of Perm Paralysis Have the Right to Forgo Life-Sustaining Therapy
Neurol 43:224-225, Bernat,J.L.,et al, 1993
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Amyotrophic Lateral Sclerosis, Recent Advances in Pathogenesis & Therapeutic Trials
Arch Neurol 45:189-202, Mitsumoto,H.,et al, 1988
Amyotrophic Lateral Sclerosis:Part 1. Clinical Features, Pathology, & Ethical Issues in Management
Ann Neurol 18:271-280, Tandan,R.,et al, 1985